Open innovation in new drug research : the Indian perspective
Bhatnagar, Bhawani and Dörfler, Viktor and MacBryde, Jillian (2015) Open innovation in new drug research : the Indian perspective. In: 22nd EurOMA 2015, 2015-06-26 - 2015-07-01, University of Neuchâtel.
Preview |
Text.
Filename: Bhatnagar_etal_EUROMA2015_open_innovation_in_new_drug_research.pdf
Accepted Author Manuscript Download (402kB)| Preview |
Abstract
This article sketches open innovation strategies pursued by eight Indian pharmaceutical firms and provides an account of strategic flexibility charted by firms in the wake of changes in the legislative environment. The findings examined through the lens of open innovation and dynamic capabilities identifies ‘technological competencies’ and ‘funding’ as two very important reasons, which push the traditionally closed R&D firms to pursue open innovation. Within the dynamic capabilities framework, the findings suggest that resources and competencies play a vital role in enabling open innovation in the complex new drug research setting.
ORCID iDs
Bhatnagar, Bhawani ORCID: https://orcid.org/0000-0003-0220-1052, Dörfler, Viktor ORCID: https://orcid.org/0000-0001-8314-4162 and MacBryde, Jillian ORCID: https://orcid.org/0000-0002-8624-6989;-
-
Item type: Conference or Workshop Item(Paper) ID code: 53511 Dates: DateEvent30 June 2015Published23 February 2015AcceptedSubjects: Social Sciences > Industries. Land use. Labor > Management. Industrial Management Department: Strathclyde Business School > Management Science Depositing user: Pure Administrator Date deposited: 29 Jun 2015 08:02 Last modified: 19 Sep 2024 00:25 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/53511